1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223–1236. [
DOI:10.1056/NEJMra041536]
2. Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, Futterweit W, et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 1998; 83: 1976-1987.
3. Guyatt G, Weaver B, Cronin L, Dooley JA, Azziz R. Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. J Clin Epidemiol 2004; 57: 1279-1287. [
DOI:10.1016/j.jclinepi.2003.10.018]
4. Jones GL, Benes K, Clark TL, Denham R, Holder MG, Haynes TJ, et al. The polycystic ovary syndrome health-related quality of life questionnaire (PCOSQ): a validation. Hum Reprod 2004; 19: 371-377. [
DOI:10.1093/humrep/deh048]
5. McCook J, Reame N, Thatcher S. Health-related quality of life issues in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 2005; 34: 12-20. [
DOI:10.1177/0884217504272945]
6. Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod 2007; 22: 2279-2286. [
DOI:10.1093/humrep/dem108]
7. Jones GL, Hall JM, Balen AH, Ledger WL. Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review. Hum Reprod Update 2008; 14: 15-25. [
DOI:10.1093/humupd/dmm030]
8. Malik-Aslam A, Reaney MD, Speight J. The suitability of polycystic ovary syndrome-specific questionnaires for measuring the impact of PCOS on quality of life in clinical trials. Value Health 2010; 13: 440-446. [
DOI:10.1111/j.1524-4733.2010.00696.x]
9. MacDermid JC. Critical appraisal of study quality for psychometric articles. Evaluation from In: Evidence-Based Rehabilitation: A guide to practice. Thorofare,New Jersey: Slack, Inc.; 2008: 387-388.
10. MacDermid JC. Critical appraisal of study quality for psychometric articles.Evaluation from In: Evidence-Based Rehabilitation:A guide to practice. Thorofare, New Jersey: Slack, Inc.; 2008: 389-392.
11. Fitzpatrick R, Davey C, Buxton MJ, Jones D. Evaluating patientbased outcome measures for use in clinical trials. Health Technol Assess 1998: 1-74.
12. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use, third edition. New York: Oxford University Press, 2003.
13. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535. [
DOI:10.1136/bmj.b2535]
14. Bazarganipour F, Ziaei S, Montazeri A, Faghihzadeh S, Frozanfard F. Psychometric properties of the Iranian version of modified Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire. Hum Reprod 2012; 27: 2729–2736. [
DOI:10.1093/humrep/des199]
15. Jedel E, Kowalski J, Stener-Victorin E. Assessment of health-related quality of life: Swedish version of polycystic ovary syndrome questionnaire. Acta Obstet Gynecol Scand 2008; 87: 1329-1335. [
DOI:10.1080/00016340802444762]
16. Coffey S, Bano G, Mason H. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the polycystic ovary syndrome questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol 2006; 22: 80-86. [
DOI:10.1080/09513590600604541]
17. Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Faghihzadeh S. Iranian version of modified Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire: discriminant and convergent validity. Iran J Reprod Med 2013; 11: 371-378.
18. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to their Development and Use, Second Edition. Oxford University Press, Oxford, 1995.
19. SooHoo NF, McDonald AP, Seiler JG, McGillivary GR. Evaluation of the construct validity of the DASH questionnaire by correlation to the SF-36. J Hand Surg Am 2002;27:537-541. [
DOI:10.1053/jhsu.2002.32964]